Myocardial ischemic preconditioning preserves postischemic function of the 26S proteasome through diminished oxidative damage to 19S regulatory particle subunits

Circulation Research

Volumn 106, Issue 12, 2010, Pages 1829-1838

  Divald, Andras ^a   Kivity, Shaye ^b   Wang, Ping ^a   Hochhauser, Edith ^b   Roberts, Beth ^c   Teichberg, Saul ^c   Gomes, Aldrin V ^d   Powell, Saul R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c North Shore Long Island Jewish Health System ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ischemia; preconditioning; reperfusion; ubiquitin proteasome system

Indexed keywords

19S PROTEIN; 26S PROTEIN; CARBONYL DERIVATIVE; HYDRAZINE DERIVATIVE; LACTACYSTIN; PROTEASOME; PROTEIN BAX; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBONYLATION; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOPRECIPITATION; ISCHEMIC PRECONDITIONING; ISOLATED HEART; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UBIQUITINATION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CORONARY OCCLUSION; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, INBRED STRAINS; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; UBIQUITIN;

EID: 77954215848     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.219485     Document Type: Article

References (34)

1. Murry CE, Jennings RB, Reimer KA. New insights into potential mechanisms of ischemic preconditioning. Circulation. 1991;84:442-445.
2. + channels and myocardial preconditioning. Circ Res. 1999;84:973-979.
3. Korge P, Honda HM, Weiss JN. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci USA. 2002;99:3312-3317.
4. Vanden Hoek TL, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res. 2000;86:541-548.
5. Khaliulin I, Schwalb H, Wang P, Houminer E, Grinberg L, Katzeff H, Borman JB, Powell SR. Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins. Free Radic Biol Med. 2004;37:1-9.
6. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani V, Guyton RA, Vinten-Johansen J. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res. 2000;45:661-670.
7. Li B, Dou QP. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci USA. 2000;97:3850-3855.
8. Powell SR. The ubiquitin proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol. 2006;291:1-19.
9. Ciechanover A, Orian A, Schwartz AL. Ubiquitin-mediated proteolysis: biological regulation via destruction. BioEssays. 2000;22:442-451.
10. Powell SR. The cardiac 26S proteasome. Regulating the regulator. Circ Res. 2006;99:342-345.
11. Powell SR, Wang P, Katzeff HL, Shringarpure R, Teoh C, Khaliulin I, Das DK, Schwalb H. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function. Essential role of the proteasome. Antioxid Redox Signal. 2005;7:538-1535
12. Das S, Powell SR, Wang P, Divald A, Nesaretnam K, Tosaki A, Cordis GA, Maulik N, Das DK. Cardioprotection with palm tocotrienol: anti-oxidant activity of tocotrienol is linked with its ability to stabilize pro-teasomes. Am J Physiol Heart Circ Physiol. 2005;289:361-367.
13. Divald A, Powell SR. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic Biol Med. 2006;40:156-164.
14. Hochhauser E, Cheporko Y, Yasovich N, Pinchas L, Offen D, Barhum Y, Pannet H, Tobar A, Vidne BA, Birk E. Bax deficiency reduces infarct size and improves long-term function after myocardial infarction. Cell Biochem Biophys. 2007;47:11-20.
15. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J. 1998;335:637-642.
16. Powell SR, Davies KJA, Divald A. Optimal determination of heart tissue 26S Proteasome activity requires maximal stimulating concentrations of ATP. J Mol Cell Cardiol. 2007;42:265-269.
17. Powell SR, Hall D, Aiuto L, Wapnir RA, Teichberg S, Tortolani AJ. Zinc improves postischemic recovery of the isolated rat heart through inhibition of oxidative stress. Am J Physiol Heart Circ Physiol. 1994;266:H2497-H2507.
18. Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, Qiao X, Bardag-Gorce F, Ping P. Mapping the murine cardiac 26S proteasome complexes. Circ Res. 2006;99:362-371.
19. Wang P, Powell SR. Decreased sensitivity associated with an altered formulation of a commercially available kit for detection of protein carbonyls. Free Rad Biol Med. In press.
20. Besche HC, Haas W, Gygi SP, Goldberg AL. Isolation of mammalian 26S proteasomes and p97/VCP complexes using the ubiquitin-like domain from HHR23B reveals novel proteasome-associated proteins. Biochemistry. 2009;48:2538-2549.
21. DeMartino GN. Purification of PA700, the 19S regulatory complex of the 26S proteasome. Methods Enzymol. 2005;398:295-306.
22. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem. 2001;276:30057-30063.
23. Powell SR, Gurzenda EM, Wahezi SE. Actin is oxidized during myo-cardial ischemia. Free Radic Biol Med. 2001;30:1171-1176.
24. Ferrell K, Wilkinson CR, Dubiel W, Gordon C. Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci. 2000;25:83-88.
25. Ishii T, Sakurai T, Usami H, Uchida K. Oxidative modification of pro-teasome: identification of an oxidation-sensitive subunit in 26 s pro-teasome. Biochemistry. 2005;44:13893-13901.
26. Gillette TG, Kumar B, Thompson D, Slaughter CA, DeMartino GN. Differential role of the C-termini of AAA subunits of PA700 (19S regulator) in asymmetric assembly and activation of the 26S proteasome. J Biol Chem. 2008;283:31813-31822.
27. Ovaa H, van Swieten PF, Kessler BM, Leeuwenburgh MA, Fiebiger E, van den Nieuwendijk AM, Galardy PJ, van der Marel GA, Ploegh HL, Overkleeft HS. Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy. Angew Chem Int Ed Engl. 2003;42:3626-3629.
28. Cai Z, Semenza GL. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res. 2005;97:1351-1359.
29. Kisselev AF, Callard A, Goldberg AL. Importance of the different pro-teolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem. 2006;281:8582-8590.
30. Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub V, Tobar A, Vidne BA. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol. 2003;284:H2351-H2359.
31. Pei XY, Dai Y, Grant S. The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells. Leukemia. 2003;17: 2036-2045.
32. Demasi M, Davies KJ. Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism. FEBS Lett. 2003;542:89-94.
33. Baek D, Nam J, Koo YD, Kim DH, Lee J, Jeong JC, Kwak SS, Chung WS, Lim CO, Bahk JD, Hong JC, Lee SY, Kawai-Yamada M, Uchimiya H, Yun DJ. Bax-induced cell death of Arabidopsis is meditated through reactive oxygen-dependent and-independent processes. Plant Mol Biol. 2004;56:15-27.
34. Cai Z, Shen Z, Kaer LV, Becker LC. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J. 2008;22: 4248-4257.